Format

Send to

Choose Destination
Curr Treat Options Neurol. 2019 Mar 21;21(4):18. doi: 10.1007/s11940-019-0557-2.

Antidepressants for Preventive Treatment of Migraine.

Author information

1
John R. Graham Headache Center, Brigham and Women's Hospital Department of Neurology, Harvard Medical School, 1153 Centre St Suite 4H, Boston, 02130, USA. rburch@partners.org.

Abstract

PURPOSE OF REVIEW:

This review describes the pharmacology of each antidepressant class as it applies to migraine prevention, summarizes the evidence base for each medication, and describes relevant side effects and clinical considerations. Use of antidepressants for migraine prevention in clinical practice is also discussed.

RECENT FINDINGS:

Antidepressants are commonly used as migraine preventives. Amitriptyline has the best evidence for use in migraine prevention. Nortriptyline is an alternative in patients who may not tolerate amitriptyline. The sedating effect of TCAs can be beneficial for patients with comorbid insomnia. SNRIs including venlafaxine and duloxetine also have evidence for efficacy and may be the most effective treatments in patients with comorbid depression and migraine. SSRIs including fluoxetine are not effective for most patients. The side effect burden of antidepressants can be substantial. Patients should be particularly counseled about the possibility of a withdrawal effect from SNRIs. Antidepressants are an important option for preventive treatment of migraine. Further research on the efficacy and tolerability of SNRIs as migraine preventives is needed.

KEYWORDS:

Antidepressants; Migraine; Prevention; SNRI; SSRI; TCA; Treatment

PMID:
30895388
DOI:
10.1007/s11940-019-0557-2

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center